Remedium Lifecare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 7,990.35 million compared to INR 2,577.8 million a year ago. Revenue was INR 8,031.11 million compared to INR 2,593.52 million a year ago. Net income was INR 117.73 million compared to INR 86.86 million a year ago. Basic earnings per share from continuing operations was INR 0.292 compared to INR 0.2154 a year ago. Diluted earnings per share from continuing operations was INR 0.292 compared to INR 0.2154 a year ago.